Načítá se...
CD4(+)CD25(+) regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling
BACKGROUND: CD4(+)CD25(+) regulatory T cells can inhibit excessive T-cell responses in vivo. We have previously demonstrated that prophylactic administration of CD4(+)CD25(+) regulatory T cells suppresses the development of acute allergen-induced airway inflammation in vivo. OBJECTIVE: We sought to...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3389733/ https://ncbi.nlm.nih.gov/pubmed/18672278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2008.05.048 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|